JLK, Inc (322510) Fair Value & Analysis
Industrials · KR · Market cap 127B KRW
Fair value as of: Aug 13, 2026
From 2 valuation models · updated today
Fair value updated Aug 13, 2026, revised from 651.67 KRW to 1,370 KRW (+110.2%) since Jul 21, 2026. Share price +22.1% over the past month.
Below-average quality, and screening another 75% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (1,713 KRW). The favourable scenario is already priced in.
- Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 2,417 KRW – 29,002 KRW · fair‑value band 1,028 KRW – 1,713 KRW · the 5,500 KRW price screens above the 1,370 KRW fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
JLK, Inc (322510) currently trades at 5,500 KRW, while our model-based Fair Value estimate is 1,370 KRW, implying the stock looks roughly 75.1% overvalued today. The Quality Score stands at 27/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 3.3B KRW. Revenue declined 15.1% year over year. It earns a return on equity of -33.5%. Net debt stands at 26.2B KRW. Fundamentals as of Aug 13, 2026
Our scenario range runs from 1,028 KRW (bear case) to 1,713 KRW (bull case); at 5,500 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 40% below its 52-week high and 46% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at 11% fair-value upside, at -75%, 322510 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Widest divergence: Multiples (1,376 KRW) versus Asset-Based (1,084 KRW). Highest evidence: P/B Multiple (55).
Notify me when 322510 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 29 · Market factors (momentum, volatility) 20
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases.
Full company description
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology. JLK, Inc. was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. was incorporated in 2014 and is based in Cheongju-si, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
JLK, Inc reported revenue of 3.3B KRW in FY2025 versus 3.8B KRW in FY2021, a compound −3.1%/yr. Reported net income was −13.6B KRW in FY2025.
322510 screens 75% overvalued. Compare with ITOCHU Corporation →
Peer Group
Conglomerates · 385 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Conglomerates median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| ITOCHU Corporation ITOCHU19 | 7.20 THB | 14.40 THB | +100% |
| SK Inc 034730 | 553,000 KRW | 615,077 KRW | +11% |
| PT Astra International Tbk, ASII | 4,860 IDR | 9,720 IDR | +100% |
| Koç Holding KCHOL | 205.80 TRY | 182.26 TRY | -11% |
| SRF Limited SRF | ₹2,585 | ₹859.71 | -67% |
| Empresas Copec S.A COPEC | 6,030 CLP | 10,809 CLP | +79% |
| Posco International Corporation 047050 | 54,300 KRW | 71,119 KRW | +31% |
| Tube Investments of India Limited TIINDIA | ₹2,839 | ₹723.80 | -75% |
| Doosan Corporation 000155 | 436,000 KRW | 93,413 KRW | -79% |
| Thermax Limited THERMAX | ₹4,002 | ₹1,343 | -66% |
Compare JLK, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is JLK, Inc (322510) overvalued or undervalued?
What is the fair value of 322510?
What is the quality score of 322510?
What is the revenue of JLK, Inc (322510)?
What is the net profit margin of 322510?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track JLK, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.